section name header

Footnotes

a Tested in dextrose 5%.

b Tested in sodium chloride 0.9%.

c Tested in sodium chloride 0.45%.

d Injected via Y-site into an administration set running azithromycin.

e Test performed using the formulation WITHOUT edetate disodium.

f Tested in dextrose 5% in sodium chloride 0.45%.

g Tested in Ringer’s injection, lactated.

h Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

i Imipenem component. Imipenem in a 1:1 fixed-ratio concentration with cilastatin.

j Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

k Test performed using the monohydrate formulation.

l Tested in both dextrose 5% and sodium chloride 0.9%.

m Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

n Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

o Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

p Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

q Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.